English | Español

Perelman School of Medicine at the University of Pennsylvania
+ Technology/Innovation
Patient Daily | Oct 17, 2023

New Study by Penn Medicine researchers could 'untangle some of the mechanisms that contribute to long COVID'
April Bamburg | Oct 4, 2015

DNA-based vaccine eliminates nearly 50 percent of cervical lesions in clinical trial

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes